A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Metastatic Prostate Cancer.
Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Papillary Thyroid Cancer.
ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their ...
Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments. A "checkpoint" receptor that often resides on the surface of ...
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.